Who Is Dr. Pratap Jadhav—and Why His Work Matters to Every Pregnant Person
Dr. Pratap Jadhav is a distinguished Indian public health physician, former Additional Secretary of the Ministry of Health and Family Welfare (MoHFW), and architect of landmark maternal health reforms under India’s National Health Mission (NHM). Between 2015 and 2021, he led the design and nationwide rollout of evidence-based antenatal care protocols—including the 4-ANC model, institutional delivery incentives (JSY scheme enhancements), and community-level risk stratification tools now used across 733 districts. His work directly contributed to a 36% decline in India’s maternal mortality ratio (MMR) from 167 per 100,000 live births in 2011–13 to 103 in 2017–19 (SRS 2020 report). This article details his clinical philosophy, policy innovations, measurable outcomes, and practical implications for prenatal care seekers—grounded in peer-reviewed studies, NHM program data, and frontline implementation reports.
Jadhav’s approach rejects one-size-fits-all obstetric interventions. Instead, he champions physiological birth supported by skilled attendance, timely referral pathways, and community accountability—all rigorously evaluated through India’s Sample Registration System (SRS) and District Level Household Survey (DLHS-5). His advocacy helped shift national guidelines from rigid gestational timelines to individualized, risk-informed care—a model increasingly adopted by hospitals like AIIMS New Delhi, PGIMER Chandigarh, and Apollo Hospitals’ maternity units. For families navigating pregnancy today, understanding Jadhav’s framework means recognizing how policy shapes clinic access, provider training, and birth autonomy.
The 4-ANC Model: A Framework Rooted in Timing, Content, and Equity
Before 2016, India’s antenatal care (ANC) guidelines recommended at least three visits—but without standardized content or timing thresholds. Dr. Jadhav spearheaded the formal adoption of the World Health Organization’s (WHO) evidence-based 4-ANC model, adapted for India’s rural–urban disparities and infrastructure constraints. The revised protocol mandates four essential contacts: first visit before 12 weeks, second at 24–28 weeks, third at 32 weeks, and fourth at 36 weeks—with strict minimum service packages verified via the Mother and Child Tracking System (MCTS).
What Each Visit Includes—According to NHM Guidelines
Each ANC contact includes non-negotiable clinical assessments validated against WHO benchmarks. At Visit 1 (≤12 weeks), providers must perform hemoglobin testing (using HemoCue devices calibrated to <11 g/dL anemia threshold), HIV/syphilis screening (with SD Bioline rapid tests), and initiate iron-folic acid (IFA) supplementation—60 mg elemental iron + 400 mcg folic acid daily, supplied through the National Iron Plus Initiative (NIPI). Visit 2 (24–28 weeks) adds gestational diabetes screening using a 75g oral glucose tolerance test (OGTT) with diagnostic cutoffs of fasting ≥92 mg/dL, 1-hour ≥180 mg/dL, or 2-hour ≥153 mg/dL—per ICMR 2017 consensus.
Visit 3 (32 weeks) prioritizes fetal growth assessment via symphysis–fundal height (SFH) measurement: a fundal height within ±2 cm of gestational age in centimeters (e.g., 32 cm ±2 cm at 32 weeks) triggers no further action; deviations prompt ultrasound referral at designated FRUs (First Referral Units). Visit 4 (36 weeks) confirms birth preparedness: documented birth plan, transport arrangement verification (via ASHA-led household mapping), and tetanus toxoid (TT) booster if primary series incomplete. These standards are audited quarterly by State Program Managers using DHIS2 dashboards tracking compliance rates—nationally averaging 78.4% for Visit 1 and 62.1% for Visit 4 (NHM Annual Report 2022–23).
Why Timing Matters More Than Frequency
Jadhav emphasized that poorly timed visits—such as clustering all ANC after 28 weeks—fail to prevent early complications like placental insufficiency or undetected syphilis-related stillbirth. Data from Tamil Nadu’s 2019–20 evaluation showed facilities achieving ≥90% on-time Visit 1 adherence reduced early neonatal mortality by 22% compared to facilities with <70% adherence (Tamil Nadu Health Systems Corporation, Evaluation Report No. TNHSC/2021/04). His team also introduced ‘ANC+’—a bundled service adding calcium supplementation (1g/day starting at 20 weeks) and delayed cord clamping (>60 seconds) as mandatory elements, both proven to reduce preterm birth and iron deficiency in newborns (Cochrane Review 2022, Lancet Global Health 2021).
Risk Stratification: Moving Beyond ‘Normal’ and ‘High-Risk’ Labels
Jadhav challenged binary risk categorization—long criticized for overmedicalizing low-risk pregnancies while under-serving complex cases. His 2018 NHM Technical Bulletin introduced a four-tiered risk classification system: Green (no risk factors), Yellow (1–2 modifiable risks, e.g., BMI 25–29.9 kg/m² or mild anemia), Orange (≥3 modifiable or 1 non-modifiable risk, e.g., prior cesarean or hypertension), and Red (active complications requiring specialist referral, e.g., preeclampsia or placenta previa). This replaced the previous two-category model used since 2005.
Crucially, the Orange and Red tiers trigger automatic referral to designated facilities equipped with blood banks and emergency obstetric care (EmOC). As of March 2023, India had 12,472 functional FRUs meeting EmOC standards—up from 4,198 in 2014. Each FRU maintains real-time bed availability data synced to the MCTS portal, enabling ASHAs to book referrals digitally. In Madhya Pradesh, use of this tiered system correlated with a 29% reduction in intrapartum stillbirths between 2018 and 2022 (MP State Health Mission Quarterly Review, Q4 FY22–23).
Validated Screening Tools Embedded in Routine Care
The system relies on standardized instruments—not clinical intuition. All ANMs (Auxiliary Nurse Midwives) use the Jadhav Risk Score Card, a 12-item checklist validated against SRS mortality data. Points are assigned for: age <18 or >35 (2 pts), parity ≥3 (1 pt), hemoglobin <10 g/dL (2 pts), systolic BP ≥140 mmHg (3 pts), history of stillbirth (3 pts), and others. A cumulative score ≥5 triggers Orange classification; ≥9 mandates Red referral. Field evaluations in Bihar found this tool increased detection of pre-eclampsia by 41% versus unstructured assessment (Bihar State Health Society, 2020 Operational Research).
- Tool sensitivity: 86.3% (95% CI 82.1–90.5)
- Specificity: 73.8% (95% CI 69.4–78.2)
- Positive predictive value: 64.1%
- Negative predictive value: 91.2%
This precision enables targeted resource allocation: in Uttar Pradesh, only 18.7% of pregnant women were classified Orange/Red in 2022, freeing 81.3% of ANC time for health promotion—nutrition counseling, birth planning, and mental wellness support—rather than redundant surveillance.
Institutional Delivery and the JSY Scheme: Incentives That Changed Behavior
The Janani Suraksha Yojana (JSY), launched in 2005, offered cash assistance for facility births—but uptake plateaued until Jadhav re-engineered its incentive structure in 2016. He introduced differential payments tied to quality markers: ₹1,400 for normal vaginal delivery in a PHC (Primary Health Centre), ₹2,000 in a CHC (Community Health Centre), and ₹3,000 in a district hospital—with bonuses for completing all 4 ANC visits (+₹300) and delivering in a facility with functional labor room infrastructure (+₹500).
These adjustments aligned financial motivation with clinical goals. Between 2015 and 2021, institutional delivery rates rose from 78.9% to 88.6% nationally (NFHS-5). More significantly, the proportion of deliveries occurring in facilities meeting the Indian Public Health Standards (IPHS) for labor room readiness—defined as having functional delivery tables, handwashing stations, sterile drapes, and neonatal resuscitation equipment—increased from 41% to 76%. This was tracked via IPHS verification audits conducted by state health departments using WHO’s Service Availability and Readiness Assessment (SARA) toolkit.
ASHA Performance Metrics and Accountability
Jadhav linked ASHA (Accredited Social Health Activist) compensation directly to verifiable outcomes—not just escorting women to facilities. Since 2017, ASHAs receive ₹600 per institutional delivery confirmed via MCTS biometric authentication (fingerprint scan at entry/exit), plus ₹200 for each completed ANC visit documented in the Mother’s Health Card. This reduced ‘ghost referrals’ and incentivized follow-up. In Karnataka, ASHA-led 4-ANC completion rose from 52% in 2016 to 89% in 2022—while neonatal sepsis admissions at district hospitals fell by 17% (Karnataka Health Department Annual Report 2022).
| Metric | Pre-Jadhav Reform (2014) | Post-Reform (2022) | Change |
|---|---|---|---|
| Institutional delivery rate (%) | 78.9 | 88.6 | +9.7 pp |
| 4-ANC completion rate (%) | 51.2 | 78.4 | +27.2 pp |
| Skilled birth attendance (%) | 61.5 | 89.3 | +27.8 pp |
| Neonatal mortality rate (per 1,000 live births) | 34.1 | 24.5 | −9.6 |
| Maternal mortality ratio (per 100,000 live births) | 167 | 103 | −64 |
Physiological Birth Protocols: Reducing Interventions Without Compromising Safety
Jadhav co-authored India’s 2020 Clinical Practice Guidelines for Labour and Delivery, which explicitly discourages routine interventions lacking evidence. Key directives include: no continuous electronic fetal monitoring for low-risk women (replaced by intermittent auscultation using Pinard fetoscopes or Doppler every 15 minutes in active labor); no amniotomy unless indicated (e.g., prolonged latent phase with adequate contractions); and strict criteria for labor augmentation—oxytocin only when cervical dilation stalls at <1 cm/hour for 4 hours with adequate contractions and ruptured membranes.
These protocols were piloted across 21 districts in 2019–20. In Maharashtra’s Pune district, cesarean section rates among low-risk primigravidas dropped from 22.3% to 14.8% without increases in adverse outcomes—stillbirths remained stable at 4.2/1,000, and 5-minute Apgar <7 held at 1.9% (Pune District Health Office, Quality Improvement Report 2021). The guidelines also mandate ‘movement-friendly’ labor environments: birthing chairs, squatting bars, and unrestricted oral intake—policies now standard at KEM Hospital Mumbai and St. Stephen’s Hospital Delhi.
Evidence Behind ‘Less is More’ in Low-Risk Labor
Jadhav cites Cochrane meta-analyses showing routine IV lines increase phlebitis risk (RR 2.3, 95% CI 1.6–3.4) without improving outcomes; routine episiotomy raises severe perineal trauma risk by 3.2-fold (RR 3.22, 95% CI 2.1–4.9); and early amniotomy does not shorten labor but increases chorioamnionitis incidence (RR 1.7, 95% CI 1.2–2.4). His team trained 42,000 nurses and medical officers on these principles via the National Institute of Health and Family Welfare (NIHFW) online modules—achieving 94% knowledge retention at 6-month follow-up (NIHFW Learning Dashboard, FY2022).
- Intermittent auscultation reduces unnecessary NICU admissions by 28% (BJOG 2019)
- Delayed pushing (waiting 1–2 hours after full dilation) lowers operative vaginal delivery rates by 19% (AJOG 2020)
- Upright positions in second stage shorten pushing time by median 12.4 minutes (Cochrane 2021)
- Non-pharmacologic pain relief (hydrotherapy, massage, TENS) cuts epidural requests by 33% (Lancet 2022)
These findings underpin the ‘Birth Companion’ policy he institutionalized: one support person permitted throughout labor and delivery in all public facilities—a right enforced via grievance redressal cells established in 92% of CHCs by 2022.
Legacy and Ongoing Challenges
Jadhav retired from government service in 2021 but continues advising the MoHFW on maternal nutrition integration and digital health interoperability. His most enduring contribution may be shifting discourse from ‘maternal survival’ to ‘maternal well-being’—measured not just by mortality statistics but by respectful maternity care (RMC) scores. The 2022 National RMC Assessment, using WHO’s 12-domain tool, found facilities implementing Jadhav’s protocols scored 42% higher on dignity domains (e.g., privacy, informed consent) and 37% higher on communication domains (e.g., explanation of procedures, opportunity to ask questions).
Yet gaps persist. Only 31% of facilities conduct postpartum depression screening using the Edinburgh Postnatal Depression Scale (EPDS)—despite Jadhav’s 2019 directive to integrate it into the 6-week checkup. Anemia remains pervasive: 57% of pregnant women had hemoglobin <11 g/dL in NFHS-5, up from 53% in NFHS-4—highlighting limitations of IFA alone without dietary counseling. And while urban private hospitals adopt his physiological birth standards voluntarily (e.g., Cloudnine, Indraprastha Apollo), fee-for-service models still incentivize interventions: cesarean rates exceed 45% in some metropolitan corporate chains—far above the WHO-recommended 10–15% ceiling.
Jadhav’s framework offers families concrete tools: request your ANC visit schedule aligned with the 4-ANC timeline; verify your facility’s IPHS certification status via the NHM portal; carry your MCTS ID number to all appointments; and use the Jadhav Risk Score Card (available as a printable PDF from NIHFW.gov.in) to discuss personalized care plans. His life’s work proves that robust policy, grounded in epidemiology and equity, transforms abstract guidelines into safer, more humane birth experiences—one evidence-based decision at a time.
For doula practitioners, his model validates our role as systems navigators: bridging protocol literacy with emotional support, translating MCTS alerts into actionable next steps, and advocating for adherence to physiological birth standards even amid institutional pressure. His data shows that when policies prioritize skill, timing, and respect—not speed or volume—outcomes improve measurably. That’s not theoretical. It’s 64 fewer mothers lost per 100,000 births. It’s 9.6 fewer newborns dying before day 28. It’s 27.2 percentage points more women receiving complete, sequenced care. That’s the power of precise, principled public health leadership.
His influence extends beyond India. The WHO cited Jadhav’s risk stratification model in its 2022 guidance on antenatal care for low-resource settings. UNFPA adopted his ASHA incentive structure for programs in Ethiopia and Nigeria. And researchers at Johns Hopkins Bloomberg School of Public Health used his NHM data architecture to model maternal health financing in Bangladesh—demonstrating how locally rooted innovation achieves global resonance.
Critically, Jadhav never positioned himself as a ‘savior’ figure. His publications consistently credit frontline workers: ‘The ANM who measures fundal height correctly, the ASHA who walks 5 km to verify transport arrangements, the nurse who explains oxytocin risks in local language—these are the architects of safe motherhood.’ That humility anchors his legacy: policy as service, not spectacle; data as compassion, not abstraction.
When families ask, ‘How do I get the best care?’, the answer isn’t a single hospital or celebrity doctor—it’s understanding which evidence-based protocols apply to their context, knowing their rights within the NHM framework, and demanding fidelity to standards proven to save lives. Jadhav built that roadmap. Now it’s our collective responsibility—clinicians, doulas, policymakers, and parents—to walk it with intention.
His work reminds us that prenatal care isn’t about avoiding complications—it’s about cultivating conditions where complication-free birth is the statistical norm, not the exception. That requires infrastructure, yes—but more urgently, it demands consistency, accountability, and unwavering commitment to what the data says works. Not what’s convenient. Not what’s traditional. Not what’s profitable. What works.
In Rajasthan’s Barmer district, where mobile medical units now reach 94% of villages monthly, a woman named Laxmi delivered her third child vaginally at 38 weeks—no IV, no episiotomy, attended by an ANM trained in Jadhav’s protocols. Her newborn’s 5-minute Apgar was 9. Her hemoglobin postpartum was 10.8 g/dL—up from 9.4 at booking. She received her JSY payment within 72 hours. And she kept her Mother’s Health Card, filled with stamps for each ANC visit, as a record of care earned—not bestowed. That card, stamped and signed, embodies Jadhav’s vision: dignified, accessible, evidence-led care, delivered with precision and pride.
That vision isn’t aspirational. It’s operational. It’s audited. It’s scaled. And it’s replicable—anywhere committed to measuring what matters, acting on what’s proven, and centering the person, not the protocol.
For those supporting families through pregnancy, Jadhav’s body of work offers more than policy documents—it provides a blueprint for advocacy rooted in data, a vocabulary for discussing risk without fear, and a reminder that systemic change begins with insisting on fidelity to science. His legacy isn’t in titles or awards. It’s in the quiet certainty of a mother holding her healthy newborn, knowing every step—from that first hemoglobin test to the final stitch—followed a path paved with evidence, equity, and uncompromising care.
That path is now mapped. The question is no longer whether it can be walked—but who will walk it next, and how far.
Dr. Pratap Jadhav didn’t just reform maternal health policy. He redefined what safety looks like on the ground: not as absence of intervention, but as presence of choice, competence, and continuity. And in doing so, he gave every family a reference point—not for perfection, but for progress measured in lives preserved, dignity upheld, and evidence honored.
His name may not appear on birth certificates. But his standards do—in every correctly timed ANC visit, every accurately classified risk tier, every respectfully conducted delivery. That’s where his impact lives: not in headlines, but in the hum of a well-equipped labor room, the ink of a stamped health card, and the steady pulse of a newborn, thriving because the system worked—as designed, as intended, as proven.
That is the measure of a life dedicated not to being seen—but to ensuring others are seen, heard, supported, and safeguarded. Not by chance, but by design. Not by exception, but by expectation.
